Who invested in Rainier Therapeutics?
Rainier Therapeutics's investors include Novo Holdings and EQT Life Sciences.
Who invested in Rainier Therapeutics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$20Mraised across 1 round since 2018, from 1 source
- Latest round
- Series B, $20MMay 2018
- Investors
- 2
The rounds
- May 2018
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Rainier Therapeutics
How much has Rainier Therapeutics raised?
Rainier Therapeutics has raised $20M across 1 round since 2018.
When did Rainier Therapeutics last raise?
Rainier Therapeutics's most recent round was a Series B of $20M in May 2018.
What was Rainier Therapeutics's biggest round?
Its most recent round, $20M in May 2018, is also its largest on record.
Who backed Rainier Therapeutics first?
Rainier Therapeutics's first round on record, in May 2018, was backed by Novo Holdings and EQT Life Sciences.
What stage is Rainier Therapeutics at?
Rainier Therapeutics's latest named round is a Series B, in May 2018.
Companies like Rainier Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.